Big data and biomarkers are improving sepsis patient outcomes

/Dr. Ron Daniels

25 May 2022

In this presentation, Dr. Ron Daniels, Executive Director and Founder of the UK Sepsis Trust, discusses sepsis, time-sensitive infection, and the interlinkage between sepsis, COVID-19, and antimicrobial resistance. Daniels also explains the importance of using big data to discover sepsis trends within the population and highlights the benefits of the public's interest in their own health in relation to infection. This talk was presented at the SelectScience® Virtual Microbiology and Infectious Disease Summit 2022.

Dr. Ron Daniels

UK Sepsis Trust

Biography

Ron Daniels is an NHS Consultant in Intensive Care, based in Birmingham, U.K. He’s also Executive Director of the UK Sepsis Trust and is Vice President of the Global Sepsis Alliance. In 2016, he was awarded the British Empire Medal for services to patients. Ron’s expertise lies in translational medicine and leadership. He leads the team driving dissemination of the Sepsis 6 treatment pathway and is part of the team responsible for much of the policy and media engagement around sepsis in the U.K. and elsewhere, including the adoption of the 2017 Resolution on Sepsis by the WHO. At home, Ron’s worked with the NHS over the past five years to ensure that, in England, more than 80% of patients presenting with suspected sepsis now receive appropriate antimicrobials rapidly. He’s ever mindful of the perceived conflict, and the synergies and need for collaboration, with the antimicrobial stewardship agenda.